Berkeley HeartLab, which Quest acquired in 2011, allegedly paid kickbacks to physicians and patients to encourage them to use its blood testing services over other laboratories’.
The government alleged Berkeley paid kickbacks to referring physicians disguised as “process and handling” fees, and paid kickbacks to patients “by routinely waiving copayments owed by certain patients who were legally required to pay for part of their tests.”
These illegal kickbacks allegedly forced federal healthcare programs to pay for medically unnecessary cardiovascular tests, the DOJ said.
The settlement came about from a lawsuit by Michael Mayes, MD, under the qui tam, or whistle-blower, provisions of the False Claims Act.
In an emailed statement to Becker’s Hospital Review, Quest said it put a stop to the illegal kickbacks soon after discovering BHL’s use of paying processing and handling fees.
More articles on legal and regulatory issues:
11 latest healthcare industry lawsuits, settlements
IU Health, HealthNet pay $18M to resolve false billing allegations
Partners, Brigham and Women’s to pay $10M to settle research fraud suit
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
